‘Milestone’ prostate cancer drug

The first drug that targets precise genetic mutations in prostate cancer has been shown to be effective in a “milestone” trial by UK scientists.
The study, at the Institute of Cancer Research in London, took place on 49 men with untreatable cancer.Read More…http://www.bbc.com/news/health-34649024